Rise in home infusion therapy leads to questions on safety, cost

Rise in home infusion therapy leads to questions on safety, cost

Patient demand, specialty drug availability and workforce shortages have driven increases in home infusion therapy. Health systems and specialty companies can administer prescription drugs intravenously in a home setting to sidestep overhead fees on brick-and-mortar operations and to reserve clinical space for more acute cases. Payers also tout potential savings.

As the practice grows, however, industry watchers are raising questions about whether cost and safety considerations could undermine its possible advantages.

Medigy Insights

To improve patient safety and cost-effectiveness in home infusion therapy (HIT), hospitals and health-tech innovators should focus on comprehensive patient screening protocols, robust training and education programs, advanced monitoring technologies, collaboration with payers and policymakers, and continuous quality improvement initiatives. By implementing these strategies, stakeholders can ensure the suitability of patients for HIT, enhance healthcare professionals' competency, utilize remote monitoring and smart infusion pumps, address reimbursement challenges, and drive ongoing improvement. These actions will contribute to safer and more efficient HIT, allowing patients to receive long-term intravenous treatments in their homes while minimizing risks and optimizing resource utilization.



Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 2, 2024 at 4:22pm